Back

Are the results of the CASTLE-AF trial reproducible in the real life? Clinical outcomes after catheter ablation for atrial fibrillation with heart failure in a nationwide cohort study

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Atrial Fibrillation - Treatment Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Arnaud Bisson

CHU de Tours, Tours (France)

41 More presentations in this session

Presentation thumbnail
Differences in thromboembolic complications between paroxysmal and persistent atrial fibrillation patients following electrical cardioversion: an analysis from the ENSURE-AF study
Professor J. Merino (Madrid, ES)
Abstract
Presentation thumbnail
Impact of initial impedance level during atrial fibrillation ablation on scar size in pulmonary vein
Doctor A. Lam (Thun, CH)
Abstract
Presentation thumbnail
Gender differences in left atrial scar burden after pulmonary vein isolation with significant impact on pulmonary vein reconnections
Doctor A. Lam (Thun, CH)
Abstract
Presentation thumbnail
Superior vena cava mapping and electrical isolation using a novel ultra-high resolution 3-dimensional mapping system
Doctor S. Miyazaki (Tokyo, JP)
Abstract
Presentation thumbnail
Is atrio-ventricular node ablation a neglected option after failure of atrial fibrillation ablation? a French nationwide cohort study
Doctor A. Bisson (Tours, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Atrial Fibrillation - Treatment

The Event

Event poster

EHRA 2019

17 March - 19 March 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources